171 related articles for article (PubMed ID: 16970264)
1. Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients: a cross sectional study of 103 patients.
Buargub MA; Nabulsi MF; Shafeh TA
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):401-7. PubMed ID: 16970264
[TBL] [Abstract][Full Text] [Related]
2. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.
Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P
J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
4. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study.
Gallieni M; Cucciniello E; D'Amaro E; Fatuzzo P; Gaggiotti A; Maringhini S; Rotolo U; Brancaccio D;
J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633
[TBL] [Abstract][Full Text] [Related]
5. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Renal Osteodystrophy and Serum Bone-Related Biomarkers in a Peritoneal Dialysis Population.
Pereira L; Magalhães J; Mendonça L; Neto R; Santos J; Carvalho CG; Oliveira A; Beco A; Frazão J
J Bone Miner Res; 2022 Sep; 37(9):1689-1699. PubMed ID: 35704534
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
[TBL] [Abstract][Full Text] [Related]
8. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
Jarava C; Armas JR; Palma A
Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and pattern of renal bone disease in end stage renal disease patients in Ile-Ife, Nigeria.
Sanusi AA; Arogundade FA; Oladigbo M; Ogini LM; Akinsola A
West Afr J Med; 2010; 29(2):75-80. PubMed ID: 20544630
[TBL] [Abstract][Full Text] [Related]
10. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
Kokuho T; Toya Y; Kawaguchi Y; Tamura K; Iwatsubo K; Dobashi Y; Nakazawa A; Takeda H; Iwatsubo M; Hirawa N; Yasuda G; Ohnishi T; Umemura S
Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
[TBL] [Abstract][Full Text] [Related]
11. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
12. The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan.
Yokoyama K; Katoh N; Kasai K; Kubo H; Murai S; Shoji R; Imamura N; Saika S; Yumita S; Ishida M; Takasu S; Kono T; Yoshida Y; Wakabayashi T; Kimua Y; Hosoya T
Ther Apher Dial; 2006 Jun; 10(3):257-61. PubMed ID: 16817790
[TBL] [Abstract][Full Text] [Related]
13. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
14. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
Moore C; Yee J; Malluche H; Rao DS; Monier-Faugere MC; Adams E; Daramola-Ogunwuyi O; Fehmi H; Bhat S; Osman-Malik Y
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1484-1493. PubMed ID: 19713297
[TBL] [Abstract][Full Text] [Related]
15. [Interest of bone alkaline phosphatase in hemodialysis patients].
Helal I; Bahlous A; El Younsi F; Ben Hamida F; Abdelmoula J; Belkahia C; Kheder A
Tunis Med; 2008 May; 86(5):427-30. PubMed ID: 19469294
[TBL] [Abstract][Full Text] [Related]
16. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
Nowak Z; Konieczna M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
[TBL] [Abstract][Full Text] [Related]
17. Differences in calcium kinetic pattern between CAPD and HD patients.
Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients.
Haas M; Leko-Mohr Z; Roschger P; Kletzmayr J; Schwarz C; Domenig C; Zsontsich T; Klaushofer K; Delling G; Oberbauer R
Am J Kidney Dis; 2002 Mar; 39(3):580-6. PubMed ID: 11877577
[TBL] [Abstract][Full Text] [Related]
19. Serum markers of bone turnover in dialyzed patients grouped by level of intact parathyroid hormone.
Grzegorzewska AE; Mlot-Michalska M
Adv Perit Dial; 2006; 22():203-6. PubMed ID: 16983970
[TBL] [Abstract][Full Text] [Related]
20. Renal osteodystrophy in pediatric patients on peritoneal dialysis.
Cano FJ; Valenzuela M; Zambrano P; Azocar MA; Wolff E; Delucchi MA; Rodriguez EE
Adv Perit Dial; 2004; 20():237-44. PubMed ID: 15384834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
